/biz/ - Business & Finance

I didn’t even know it was ASCO? Where are the biotech fags to tell us what catalysts are due?

>>16964333
Triple trips, very checked.

Lol price target... I’m just holding the shares I have left after selling the bottom like an asshole. Then I didn’t buy back in when Baker Bros bought in, like a retard. Raymond James says $2.50 price target. I’m hoping it tanks back to the pennies so I can buy. I’m so sorry for doubting you Leap!

I’m gonna just the hold these until they make it and get bought out or fail every trial and go bankrupt. I guess they could dilute, I haven’t been paying too close attention... but it’s a $50 million company, and they’re working with Beigene and have good results on their Keytruda trial. Merck could buy them out no sweat.

Beigene... seems promising. Pic related.